We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Itasca Wines is a Hampshire-based vineyard and winery that produces fine English wines. The company is raising funds for its contract winemaking facility, to fulfil the growing demand from vineyards. There are over 760 vineyards in the UK currently, 111 have their own winery and only a handful of these provide contract winemaking services to other vineyards. Itasca Wines aims to become a major winemaker and create award-winning wines at Penn Croft. The company planted its first vineyard of 16,000 vines in May 2019 and has featured in Vineyard Magazine in February and May 2019.

Pitch Rated

76%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,147,003
Active Food Systems, trading as Synergy Grill, has developed and patented innovative and commercial cooking technology for the food and hospitality industry. Its ‘Fat Atomising Grill' makes cleaning quick and easy while delivering cost savings through a 59% reduction in fuel consumption. The company has sold 2000+ units of the grill to entities like Whitbread, Greene King, Marriott, Radisson and Marstons among others. Synergy Grill asserts that its performance in the first half of the year has been profitable despite COVID-19. They have contracts with reputed organisations like Whitbread and Marstons have generated revenues of £970,000. The company is in conversation with over 50 pubs and restaurants including product trials with Nandos, Weatherspoons and Mitchell Butler that are interested in its product. It will use the investment to grow its business across different verticals.
days to go: Expired investment: £316,488
The mission at sano is to bring education and knowledge to everybody, so that they can eat healthly and take control of their own health. The strategy behind Sano to go is to become a leader in the healthy food delivery market.
days to go: Expired investment: Withheld
Qure are an affordable and convenient on-demand healthcare service providing a doctor to users doors within 2 hours, 24/7. The hassle-free healthcare connects individuals with highly-experienced medical practitioners in the local area. 
days to go: Expired investment: £720,000
The Ticket Bank (TTB) is an online ticketing marketplace that provides event tickets to disadvantaged and marginalised individuals free of charge. The company is powered by 'Tickets for Good'. It works with event organisers, charities, and community organisations to distribute otherwise unused event tickets to beneficiaries, creating unique life experiences that provide wide-ranging benefits to the health and wellbeing of its target audience. The platform already supports over 500+ charity partners who can choose tickets from over 50 venues/entertainment partners. The company introduced the 'Virtual Ticket Bank' and 'The Giving Back campaign' in the COVID-19 pandemic wherein it is sourcing thousands of tickets for National Health Service (NHS) and frontline care workers to express its gratitude for their services. They can use these tickets when the lockdown is over. The company will use the investment to create the integrations and data gathering tools to rapidly grow its channels, as well as, create additional value for both its charity and venue clients.

Pitch Rated

45%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £145,246
EarlyBird have created a number of different healthy snack packs, all made with fresh ingredients. EarlyBird deliver their snacks straight to your door meaning you don't have to leave the comfort of your home. 
days to go: Expired investment: £168,000
In My Kitchen is a platform that aims to bring together a network of professional and semi-professional chefs to sell their signature dishes and recipes online. The platform was founded in July 2020. In My Kitchen asserts that its business model holds precedence in a time where takeaways have grown in popularity in the UK because of COVID-19. It gives many chefs who have become unemployed or have fewer shifts for developing their creativity and skills whilst allowing them to earn through the gig-economy. The company has a network of more than 70 chefs across London, with backgrounds across a range of cuisines. With the investment received, the company will develop its team and company infrastructure.

Pitch Rated

31%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph